ExLibris header image
SFX Logo
Title: Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole‐cell inactivated pneumococcal vaccine
Source:

Immunology and Cell Biology [0818-9641] David, Shannon yr:2019


Collapse list of basic services Basic
Full text
Full text available via Wiley Online Library Full Collection 2019
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Construction and evaluation of a whole-cell pneumococcal vaccine candidate." Journal of applied microbiology. 125.6: 1901-1910. Link to SFX for this item
2. Leite, P. "Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability." Vaccine 32.9 (2014): 1113-1120. Link to SFX for this item
3. Moffitt, Kristin L. "Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine." Vaccine 30.29 (2012): 4316-22. Link to SFX for this item
4. Launay, Odile e. "Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial." Vaccine 27.8 (2009): 1184-9. Link to SFX for this item
5. Ford, Julian D. "Randomized Clinical Trial Comparing Affect Regulation and Supportive Group Therapies for Victimization-related PTSD with Incarcerated Women." Behavior therapy 44.2 (2012): 262-276. Link to SFX for this item
6. Zhu, F. "Reactogenicity and Immunogenicity of an Enterovirus 71 Vaccine in Chinese Healthy Children and Infants." The Pediatric infectious disease journal 31.11 (2012): 1158-1165. Link to SFX for this item
7. Holzer, Georg W. "Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection." Vaccine 29.24 (2011): 4132-41. Link to SFX for this item
8. Appaiahgari, Nita B. "A dose-escalation safety and immunogenicily study of live attenuated oral rotavirus vaccine 116E in Infants: A randomized, double-blind, placebo-controlled trial." The Journal of infectious diseases 200.3 (2009): 421-429. Link to Full Text for this item Link to SFX for this item
9. Bourgeois, R. "Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate." Vaccine 27.49 (2008): 3291-6. Link to SFX for this item
10. Rodrigues, F. "Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity." Vaccine 30.26 (2012): 3951-3957. Link to SFX for this item
11. Clutterbuck, Elizabeth A. "Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells." The Journal of infectious diseases 205.9 (2012): 1408-1416. Link to Full Text for this item Link to SFX for this item
12. Lu, Y. "GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis." Vaccine 28.47 (2010): 7468-7475. Link to SFX for this item
13. Kamaraj, G. "Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus." Research in veterinary science 85.3 (2008): 589-594. Link to SFX for this item
14. FRANKS, F. "ACCELERATED STABILITY TESTING OF BIOPRODUCTS - ATTRACTIONS AND PITFALLS." Trends in biotechnology 12.4 (1994): 114-117. Link to Full Text for this item Link to SFX for this item
15. Mckee, Amy S S. "How do adjuvants work? Important considerations for new generation adjuvants." Immunity 27.5 (2007): 687-690. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.